Ozempic has garnered a great deal of mainstream attention as a medication for supporting weight loss, but its often overlooked as a potential addition to a diabetes management plan
Discovery and history Discovered in 1973 by Dr
Rapidly growing consumer awareness, combined with high unit costs and expanding clinical eligibility, has increased the complexity and financial implications for employer-sponsored health plans
In 2023, the FDA cleared a separate brand name, Zepbound, which contains the same active ingredient tirzepatide
Conversely, autophagic deficiency acts as a triggering factor for other death pathways (79)
Demand for GLP-1s is expected to rise as new uses for the drugs beyond diabetes and obesity (such as for heart, kidney and brain health) are discovered, and market innovation and competition make them more accessible for consumers, according to Canada Beefs Beef Watch report, Growing use of GLP-1 drugs Considerations for the beef industry